Myriad Genetics, Inc. · NASDAQ:MYGN
Myriad Genetics, Inc. shareholders
As of Jun 30, 2026, 190 institutions reported holding Myriad Genetics, Inc., 94.1% of its shares. Largest: BlackRock, Vanguard and Millennium. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Myriad Genetics, Inc. | Change | Filed |
|---|---|---|---|---|
| BlackRock | 10.9M | 11.4% | +2M | Aug 7, 2026 |
| Vanguard | 7.98M | 8.3% | +601K | Aug 13, 2026 |
| Millennium | 6.62M | 6.9% | −48,445 | Aug 14, 2026 |
| Vestal Point Capital, LP | 5.74M | 6.0% | +4.09M | Aug 14, 2026 |
| State Street | 4.99M | 5.2% | +561K | Aug 7, 2026 |
| D. E. Shaw & Co., Inc. | 4.58M | 4.8% | +82,359 | Aug 14, 2026 |
| Acadian Asset Management LLC | 3.13M | 3.3% | +818K | Aug 13, 2026 |
| AQR Capital Management LLC | 2.77M | 2.9% | +854K | Aug 14, 2026 |
| Morgan Stanley | 2.48M | 2.6% | −688K | Aug 13, 2026 |
| Geode Capital | 2.42M | 2.5% | +96,818 | Aug 12, 2026 |